In the BioHarmony Drug Report Database

"Preview" Icon

Bromfenac

Bromday, Bromsite, Prolensa, Xibrom, Yellox (bromfenac) is a small molecule pharmaceutical. Bromfenac was first approved as Bromday on 2005-03-24. It is used to treat eye pain, inflammation, and postoperative pain in the USA. It has been approved in Europe to treat ophthalmologic surgical procedures and postoperative pain. The pharmaceutical is active against prostaglandin G/H synthase 1. In addition, it is known to target DNA polymerase III subunit beta. Prolensa’s patents are valid until 2033-11-11 (FDA).

 

Trade Name

 

Yellox
 

Common Name

 

bromfenac
 

ChEMBL ID

 

CHEMBL1077
 

Indication

 

eye pain, inflammation, ophthalmologic surgical procedures, postoperative pain
 

Drug Class

 

Anti-inflammatory agents (acetic acid derivatives)

Image (chem structure or protein)

Bromfenac structure rendering